Company: G
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0001140361-25-013031
Chunk: 55

Company: Genpact LTD
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 55
---
 represents the change in pension value with respect to the Gratuity Plan benefit for Mr. Mehta that is required to be provided to all employees in India pursuant to Indian law. Assumptions used in the calculation of this amount are included in Note 16, “Employee benefit plans,” to our audited consolidated financial statements for the fiscal year ended December 31, 2024 included in our Annual Report on Form 10-K. |

| (10) | The amount shown consists of the following payments and benefits to Mr. Nanduru: (a) $2,212 in life insurance plan premiums, (b) $5,068 in costs related to our executive health examination program, (c) $13,800 in matching contributions to our 401(k) plan and (d) $377 in wellness benefits. |

| (11) | The amount shown consists of the following payments and benefits to Ms. Vashisht: (a) $5,330 in life insurance plan premiums and (b) $13,800 in matching contributions to our 401(k) plan. |

| (12) | All amounts shown for Mr. Tyagarajan and Mr. Mehta are dollar-denominated amounts. For Mr. Tyagarajan, all amounts other than those shown under the “Non-equity incentive plan compensation” and “Share awards” columns were paid or incurred in U.K. pounds sterling. For Mr. Mehta, all amounts other than those shown under the “Share awards” columns were paid or incurred in Indian rupees. The exchange rate used to calculate amounts in the Summary compensation table reflecting such payments was INR 1/US$ 0.0120. |

| (13) | Mr. Tyagarajan stepped down as our President and Chief Executive Officer, effective as of February 9, 2024. Mr. Tyagarajan did not receive any severance or other termination benefits other than benefits provided generally to U.K.-based employees upon any termination of employment. See footnote 6 above. Mr. Tyagarajan continues to serve as a member of our board until the date of the 2025 annual meeting at which he will not stand for re-election. |

| (14) | Mr. Kalra served as our Senior Vice President and Global Business Leader for our Financial Services and Consumer and Healthcare segments until his promotion to President, Chief Executive Officer and Director, effective as of February 9, 2024. |

| (15) | Mr. Mehta was